Highly differentiated gastric neuroendocrine tumor in a 16-year-old patient
https://doi.org/10.21682/2311-1267-2026-13-1-98-103
Abstract
We would like to present a clinical case of an extremely rare gastric tumor in a 16-year-old adolescent – gastric neuroendocrine tumor. Only 17 cases of gastric neuroendocrine tumors have been described in foreign literature, and there are no domestic publications on this topic. Due to the rarity of this tumor in children and adolescents and the lack of clear criteria for treatment no specific therapy has been developed at the present time, and the optimal treatment is maximal surgical removal of the tumor.
About the Authors
A. O. BogdanovaRussian Federation
Endoscopist of the Department of Endoscopy
23 Kashirskoe Shosse, Moscow, 115522
R. S. Savosin
Russian Federation
Endoscopist of the Department of Endoscopy
23 Kashirskoe Shosse, Moscow, 115522
D. V. Rybakova
Russian Federation
Cand. of Sci. (Med.), Pediatric Oncologist of the Pediatric Oncology Department of Surgical Treatment Methods at the Research Institute of Pediatric Oncology and Hematology named after Academician of the Russian Academy of Medical Sciences L.A. Durnov
23 Kashirskoe Shosse, Moscow, 115522
Yu. P. Kuvshinov
Russian Federation
Dr. of Sci. (Med.), Professor, Scientific Consultant, Endoscopist of the Department of Endoscopy
23 Kashirskoe Shosse, Moscow, 115522
V. V. Delektorskaya
Russian Federation
Dr. of Sci. (Med.), Professor, Leading Researcher, Pathologist of the Pathology Department
23 Kashirskoe Shosse, Moscow, 115522
А. A. Markovich
Russian Federation
Cand. of Sci. (Med.), Senior researcher, Oncologist of the Polyclinic Department
23 Kashirskoe Shosse, Moscow, 115522
References
1. Niederle M.B., Hackl M., Kaserer K., Niederle B. Gastroenteropancreatic neuroendocrine tumours: the current incidence and staging based on the WHO and European Neuroendocrine Tumour Society classification: an analysis based on prospectively collected parameters. Endocr Relat Cancer. 2010;17(4):909–18. doi: 10.1677/ERC-10-0152. PMID: 20702725.
2. Bordi C. Gastric carcinoids. Ital J Gastroenterol Hepatol. 1999;31 Suppl 2:S94–7. PMID: 10604110.
3. Rindi G., Luinetti O., Cornaggia M., Capella C., Solcia E. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology. 1993;104(4):994–1006.
4. Rindi G., Bordi C., Rappel S., La Rosa S., Stolte M., Solcia E. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology, and behavior. World J Surg. 1996;20(2):168–72. doi: 10.1007/s002689900026. PMID: 8661813.
5. Borch K., Renvall H., Liedberg G. Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology. 1985;88(3):638–48. doi: 10.1016/0016-5085(85)90131-3. PMID: 2578420.
6. Solcia E., Bordi C., Creutzfeldt W., Dayal Y., Dayan A.D., Falkmer S., Grimelius L., Havu N. Histopathological classification of nonantral gastric endocrine growths in man. Digestion. 1988;41(4):185–200. doi: 10.1159/000199786. PMID: 3072229.
7. Carney J.A., Go V.L., Fairbanks V.F., Moore S.B., Alport E.C., Nora F.E. The syndrome of gastric argyrophil carcinoid tumors and nonantral gastric atrophy. Ann Intern Med. 1983;99(6):761–6. doi: 10.7326/0003-4819-99-6-761. PMID: 6197001.
8. Bordi C., Yu J.Y., Baggi M.T., Davoli C., Pilato F.P., Baruzzi G., Gardini G., Zamboni G., Franzin G., Papotti M. Gastric carcinoids and their precursor lesions. A histologic and immunohistochemical study of 23 cases. Cancer. 1991;67(3):663–72. doi: 10.1002/10970142(19910201)67:3<663::aid-cncr2820670323>3.0.co;2-l. PMID: 1702355.
9. Sjöblom S.M., Sipponen P., Karonen S.L., Järvinen H.J. Mucosal argyrophil endocrine cells in pernicious anaemia and upper gastrointestinal carcinoid tumours. J Clin Pathol. 1989;42(4):371–7. doi: 10.1136/jcp.42.4.371. PMID: 2715350; PMCID: PMC1141907.
10. Stockbrügger R.W., Menon G.G., Beilby J.O., Mason R.R., Cotton P.B. Gastroscopic screening in 80 patients with pernicious anaemia. Gut. 1983;24(12):1141–7. doi: 10.1136/gut.24.12.1141. PMID: 6642278. PMCID: PMC1420244.
11. Gough D.B., Thompson G.B., Crotty T.B., Donohue J.H., Kvols L.K., Carney J.A., Grant C.S., Nagorney D.M. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg. 1994;18(4):473–9; discussion 479–80. doi: 10.1007/BF00353739. PMID: 7725731.
12. Rappel S., Altendorf-Hofmann A., Stolte M. Prognosis of gastric carcinoid tumours. Digestion. 1995;56(6):455–62. doi: 10.1159/000201276. PMID: 8536814.
13. Modlin I.M., Gilligan C.J., Lawton G.P., Tang L.H., West A.B., Darr U. Gastric carcinoids. The Yale Experience. Arch Surg. 1995;130(3):250–5; discussion 255–6. doi: 10.1001/archsurg.1995.01430030020003. PMID: 7887791.
14. Wilander E., El-Salhy M., Pitkänen P. Histopathology of gastric carcinoids: a survey of 42 cases. Histopathology. 1984;8(2):183–93. doi: 10.1111/j.1365-2559.1984.tb02335.x. PMID: 6724533.
15. Thomas R.M., Baybick J.H., Elsayed A.M., Sobin L.H. Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients. Cancer. 1994;73(8):2053–8. doi: 10.1002/10970142(19940415)73:8<2053::aid-cncr2820730807>3.0.co;2-0. PMID: 8156510.
16. Cattan D., Roucayrol A.M. Endocrinopathie fundique de la gastrite atrophique fundique avec achlorhydrie. II – Les tumeurs carcinoïdes [Fundic endocrinopathy in fundic atrophic gastritis with achlorhydria. II – Carcinoid tumors]. Gastroenterol Clin Biol. 1991;15(5(Pt 2)):36C–40C. [In French]. PMID: 1916117.
17. Kanthan R., Saxena A., Kanthan S.C. Goblet cell carcinoids of the appendix: immunophenotype and ultrastructural study. Arch Pathol Lab Med. 2001;125(3):386–90. doi: 10.5858/2001-125-0386-GCCOTA. PMID: 11231488.
18. Schindl M., Kaczirek K., Passler C., Kaserer K., Prager G., Scheuba C., Raderer M., Niederle B. Treatment of small intestinal neuroendocrine tumors: is an extended multimodal approach justified? World J Surg. 2002;26(8):976–84. doi: 10.1007/s00268-002-6628-6. Epub 2002 May 21. PMID: 12016477.
19. Yıldırım Ü.M., Koca D., Kebudi R. Gastroenteropancreatic neuroendocrine tumors in children and adolescents. Turk J Pediatr. 2024;66(3):332–9. doi: 10.24953/turkjpediatr.2024.4526. PMID: 39024601.
20. Koca T., Dereci S., Karahan N., Akcam M. Gastrointestinal neuroendocrine tumors in two children. Indian Pediatr. 2016;53(1):70–2. PMID: 26840681.
21. Gumuscu B., Norwood K., Parker G.A., Bridges C.L., Rountree C.B. Well-differentiated neuroendocrine tumor of the stomach: a rare case at an uncommon site. Medicine (Baltimore). 2016;95(29):e4260. doi: 10.1097/MD.0000000000004260. PMID: 27442656; PMCID: PMC5265773.
22. Rindi G., Klöppel G., Alhman H., Caplin M., Couvelard A., de Herder W.W., Erikssson B., Falchetti A., Falconi M., Komminoth P., Körner M., Lopes J.M., McNicol A.M., Nilsson O., Perren A., Scarpa A., Scoazec J.Y., Wiedenmann B. TNM staging of foregut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch. 2006;449:395–401. doi: 10.1007/s00428-006-0250-1. PMID: 16967267.
23. Kidd M., Modlin I.M., Mane S.M., Camp R.L., Eick G.N., Latich I., Zikusoka M.N. Utility of molecular genetic signatures in the delineation of gastric neoplasia. Cancer. 2006;106(7):1480–8. doi: 10.1002/cncr.21758. PMID: 16502410.
24. Kidd M., Modlin I.M., Mane S.M., Camp R.L., Shapiro M.D. Q RT-PCR detection of chromogranin A: a new standard in the identification of neuroendocrine tumor disease. Ann Surg. 2006;243(2):273–80. doi: 10.1097/01.sla.0000197734.28551.0f. PMID: 16432362; PMCID: PMC1448909.
Review
For citations:
Bogdanova A.O., Savosin R.S., Rybakova D.V., Kuvshinov Yu.P., Delektorskaya V.V., Markovich А.A. Highly differentiated gastric neuroendocrine tumor in a 16-year-old patient. Russian Journal of Pediatric Hematology and Oncology. 2026;13(1):98-103. (In Russ.) https://doi.org/10.21682/2311-1267-2026-13-1-98-103
JATS XML


























